La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MEDICLIN Salute del bilancio

Salute finanziaria criteri di controllo 3/6

MEDICLIN ha un patrimonio netto totale di €198.5M e un debito totale di €92.7M, che porta il suo rapporto debito/patrimonio netto a 46.7%. Le sue attività totali e le sue passività totali sono rispettivamente €889.6M e €691.1M. L'EBIT di MEDICLIN è €37.2M rendendo il suo rapporto di copertura degli interessi 1.8. Ha liquidità e investimenti a breve termine pari a €113.5M.

Informazioni chiave

46.7%

Rapporto debito/patrimonio netto

€92.71m

Debito

Indice di copertura degli interessi	1.8x
Contanti	€113.46m
Patrimonio netto	€198.47m
Totale passività	€691.14m
Totale attività	€889.61m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Pinning Down MEDICLIN Aktiengesellschaft's (ETR:MED) P/S Is Difficult Right Now

Mar 29

Here's Why MEDICLIN (ETR:MED) Has A Meaningful Debt Burden

Oct 27

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

May 19

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

Feb 18

MEDICLIN's (ETR:MED) Stock Price Has Reduced 44% In The Past Three Years

Dec 07

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( €308.1M ) di MED superano le sue passività a breve termine ( €183.4M ).

Passività a lungo termine: Le attività a breve termine di MED ( €308.1M ) non coprono le sue passività a lungo termine ( €507.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: MED ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di MED è aumentato da 45.2% a 46.7% negli ultimi 5 anni.

Copertura del debito: Il debito di MED è ben coperto dal flusso di cassa operativo ( 84.4% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di MED non sono ben coperti dall'EBIT ( 1.8 x copertura).

MEDICLIN Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Here's Why MEDICLIN (ETR:MED) Has A Meaningful Debt Burden

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

Recent updates

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Second quarter 2024 earnings released: EPS: €0.01 (vs €0.23 in 2Q 2023)

First quarter 2024 earnings released: €0.03 loss per share (vs €0.13 loss in 1Q 2023)

Pinning Down MEDICLIN Aktiengesellschaft's (ETR:MED) P/S Is Difficult Right Now

MEDICLIN Aktiengesellschaft, Annual General Meeting, Jun 06, 2024

Full year 2023 earnings released: €0.23 loss per share (vs €0.20 profit in FY 2022)

MEDICLIN Aktiengesellschaft to Report Fiscal Year 2023 Final Results on Mar 26, 2024

Now 22% undervalued

MEDICLIN Aktiengesellschaft to Report First Half, 2024 Results on Jul 31, 2024

Third quarter 2023 earnings released: EPS: €0.22 (vs €0.043 in 3Q 2022)

MEDICLIN Aktiengesellschaft Appoints Thomas Piefke as A Member of Management Board. Effective October 1, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: €0.23 (vs €0.13 in 2Q 2022)

First quarter 2023 earnings released: €0.13 loss per share (vs €0.081 loss in 1Q 2022)

Mercurius Health, S.A. completed the acquisition of MEDICLIN Robert Janker Klinik from MEDICLIN Aktiengesellschaft.

MEDICLIN Aktiengesellschaft to Report Nine Months, 2023 Results on Nov 03, 2023

Now 20% undervalued

Price target increased to €6.10

Now 20% undervalued

Investor sentiment improved over the past week

Here's Why MEDICLIN (ETR:MED) Has A Meaningful Debt Burden

Second quarter 2022 earnings released: €0.13 loss per share (vs €0.08 loss in 2Q 2021)

MEDICLIN Aktiengesellschaft Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: €0.08 loss per share (vs €0.24 loss in 1Q 2021)

Full year 2021 earnings released: EPS: €0.03 (vs €0.19 loss in FY 2020)

MEDICLIN Aktiengesellschaft to Report Fiscal Year 2021 Results on Mar 30, 2022

Third quarter 2021 earnings released: EPS €0.22 (vs €0.14 in 3Q 2020)

Chairman of Management Board & CEO Volker Hippler has left the company

Second quarter 2021 earnings released: €0.08 loss per share (vs €0.12 loss in 2Q 2020)

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

MEDICLIN AG Provides Earnings Guidance for the Year 2021

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

New 90-day high: €4.42

Mediclin AG Appoints York Dhein as Additional Member to the Management Board, Effective April 1, 2021

New 90-day high: €4.00

MEDICLIN's (ETR:MED) Stock Price Has Reduced 44% In The Past Three Years

MEDICLIN Aktiengesellschaft, Annual General Meeting, May 27, 2021

Third quarter 2020 earnings released: EPS €0.12

MEDICLIN Aktiengesellschaft to Report Q1, 2021 Results on May 03, 2021

New 90-day low: €3.70

MediClin AG Announces Reliable Forecast for the 2020 Financial Year Is Not Yet Possible

District of Ludwigslust-Parchim signed a letter of intent to acquire an unknown stake in MediClin Krankenhaus am Crivitzer See GmbH from MEDICLIN Aktiengesellschaft (XTRA:MED).

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane